The latest information about BioMark Diagnostics to keep you up to date.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 BioMark is
From Black Plastics to Biomarkers How Environmental Causes of Cancer Can Be Prevented Seemingly harmless
Cancer is Rising Among Young Women: Early Detection of Lung Cancer Lung cancer rates are
Cancer Prevention: 5 Actionable Steps Take control of your health and reduce your cancer risk
BioMark’s Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered
BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection BioMark
BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify
BioMark Diagnostics Completes Testing of Over 5,400 subjects as Part of a Validation Study for
Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright’s 26th Annual Global Investment
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]